Mainz Biomed Nv Share Price (NASDAQ: MYNZ)

$1.66

▲

0.01

(0.61%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Mainz Biomed Nv Stock chart to analyse performance

Mainz Biomed Nv stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$1.63
Today's High:$1.66
$1.66
1.81%
Downside
Day's Volatility :1.81%
Upside
0.0%
52 Weeks Low:$1.30
52 Weeks High:$16.32
$1.66
21.69%
Downside
52 Weeks Volatility :92.03%
Upside
89.83%

Mainz Biomed Nv Stock Returns

Period	Mainz Biomed Nv	Index (Russel 2000)
3 Months	-19.61%	0.0%
6 Months	-67.65%	0.0%
1 Year	-89.56%	0.0%
3 Years	-99.52%	-4.7%

Mainz Biomed Nv Key Stats

Check Mainz Biomed Nv key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$1.65
Open	$1.65
Today's High	$1.66
Today's Low	$1.63
Market Capitalization	$7.6M
Today's Volume	$43.2K
52 Week High	$16.32
52 Week Low	$1.3
Revenue TTM	$894.0K
EBITDA	$-17.7M
Earnings Per Share (EPS)	$-22.36
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-465.82%

Stock Returns calculator for Mainz Biomed Nv Stock including INR - Dollar returns

The Mainz Biomed Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Mainz Biomed Nv investment value today

Current value as on today

₹15,844

Returns

₹84,156

(-84.16%)

Returns from Mainz Biomed Nv Stock

₹89,440 (-89.44%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Mainz Biomed Nv Stock

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Mainz Biomed Nv Stock from India on INDmoney has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Mainz Biomed Nv

Name
Holdings %
Name
Holdings %
Armistice Capital, LLC
12.29%
Morgan Stanley - Brokerage Accounts
0.96%
Journey Advisory Group, LLC
0.65%
Virtu Financial LLC
0.44%
UBS Group AG
0.08%
Advisor Group Holdings, Inc.
0.05%

Analyst Recommendation on Mainz Biomed Nv Stock

Rating

Trend

Buy

77%Buy

22%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Mainz Biomed Nv(by analysts ranked 0 to 5 stars)

Mainz Biomed Nv Share Price Target

What analysts predicted

Upside of 743.37%

Target:

$14.00

Current:

$1.66

Mainz Biomed Nv share price target is $14.00, a slight Upside of 743.37% compared to current price of $1.66 as per analysts' prediction.

Mainz Biomed Nv Stock Insights

Price Movement
In the last 7 days, MYNZ stock has moved down by -6.3%
Decreasing Revenue
Revenue is down for the last 2 quarters, 520.77K → 373.21K (in $), with an average decrease of 28.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -11.02M → -10.62M (in $), with an average increase of 3.7% per quarter
MYNZ vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 34.2% return, outperforming this stock by 122.6%
MYNZ vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 85.1% return, outperforming this stock by 184.6%
Price to Sales
ForMYNZ every $1 of sales, investors are willing to pay $1.8, whereas for Idexx Laboratories, Inc., the investors are paying $13.0 for every $1 of sales.

Mainz Biomed Nv Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$281.4K	-
Net Income	$-1.2M	-
Net Profit Margin	-417.48%	-

	FY20	Y/Y Change
Revenue	$493.6K	↑ 75.4%
Net Income	$-886.2K	↓ 24.57%
Net Profit Margin	-179.55%	↑ 237.93%

	FY21	Y/Y Change
Revenue	$577.3K	↑ 16.98%
Net Income	$-12.1M	↑ 1262.29%
Net Profit Margin	-2.1K%	↓ 1911.44%

	FY22	Y/Y Change
Revenue	$529.9K	↓ 8.22%
Net Income	$-26.5M	↑ 119.12%
Net Profit Margin	-5.0K%	↓ 2901.25%

	FY23	Y/Y Change
Revenue	$895.5K	↑ 69.0%
Net Income	$-26.3M	↓ 0.59%
Net Profit Margin	-2.9K%	↑ 2055.74%

	FY24	Y/Y Change
Revenue	$894.0K	↓ 0.17%
Net Income	$-21.7M	↓ 17.66%
Net Profit Margin	-2.4K%	↑ 514.7%

Q2 FY23

Q3 FY23

Q4 FY23

Q1 FY24

Q3 FY24

Q4 FY24

	Q2 FY23	Q/Q Change
Revenue	$500.2K	↑ 98.97%
Net Income	$-13.3M	↑ 5.51%
Net Profit Margin	-2.7K%	↑ 2349.56%

	Q3 FY23	Q/Q Change
Revenue	$181.7K	↓ 63.68%
Net Income	$-6.3M	↓ 52.52%
Net Profit Margin	-3.5K%	↓ 815.1%

	Q4 FY23	Q/Q Change
Revenue	$214.8K	↑ 18.22%
Net Income	$-5.2M	↓ 17.72%
Net Profit Margin	-2.4K%	↑ 1054.18%

	Q1 FY24	Q/Q Change
Revenue	$214.8K	↑ 0.0%
Net Income	$-5.2M	↑ 0.0%
Net Profit Margin	-2.4K%	↑ 0.0%

	Q3 FY24	Q/Q Change
Revenue	$520.8K	↑ 142.49%
Net Income	$-11.0M	↑ 112.68%
Net Profit Margin	-2.1K%	↑ 296.72%

	Q4 FY24	Q/Q Change
Revenue	$373.2K	↓ 28.33%
Net Income	$-10.6M	↓ 3.6%
Net Profit Margin	-2.8K%	↓ 730.56%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$-61.3K	-

	FY20	Y/Y Change
Profit	$123.1K	↓ 300.89%

	FY21	Y/Y Change
Profit	$177.6K	↑ 44.31%

	FY22	Y/Y Change
Profit	$182.2K	↑ 2.55%

	FY23	Y/Y Change
Profit	$509.7K	↑ 179.8%

	FY24	Y/Y Change
Profit	$574.9K	↑ 12.8%

Q2 FY23

Q3 FY23

Q4 FY23

Q1 FY24

Q3 FY24

Q4 FY24

	Q2 FY23	Q/Q Change
Profit	$277.9K	↑ 731.76%

	Q3 FY23	Q/Q Change
Profit	$87.2K	↓ 68.62%

	Q4 FY23	Q/Q Change
Profit	$134.7K	↑ 54.54%

	Q1 FY24	Q/Q Change
Profit	$40.3K	↓ 70.13%

	Q3 FY24	Q/Q Change
Profit	$319.0K	↑ 692.62%

	Q4 FY24	Q/Q Change
Profit	$255.8K	↓ 19.81%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-416.5K	-
Investing Cash Flow	$-9.7K	-
Financing Cash Flow	$424.0K	-

	FY20	Y/Y Change
Operating Cash Flow	$-468.7K	↑ 12.54%
Investing Cash Flow	$-9.7K	↑ 0.0%
Financing Cash Flow	$396.7K	↓ 6.44%

	FY21	Y/Y Change
Operating Cash Flow	$-3.2M	↑ 587.02%
Investing Cash Flow	$1.2M	↓ 12522.83%
Financing Cash Flow	$10.6M	↑ 2574.83%

	FY22	Y/Y Change
Operating Cash Flow	$-14.8M	↑ 358.64%
Investing Cash Flow	$-658.5K	↓ 154.73%
Financing Cash Flow	$23.9M	↑ 125.66%

	FY23	Y/Y Change
Operating Cash Flow	$-21.9M	↑ 48.54%
Investing Cash Flow	$-1.9M	↑ 188.37%
Financing Cash Flow	$14.2M	↓ 40.58%

	FY24	Y/Y Change
Operating Cash Flow	$-17.1M	↓ 22.1%
Investing Cash Flow	$-198.8K	↓ 89.53%
Financing Cash Flow	$16.6M	↑ 16.68%

Q2 FY23

Q1 FY24

Q3 FY24

Q4 FY24

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-5.1M	↓ 38.42%
Investing Cash Flow	$-123.6K	↓ 69.55%
Financing Cash Flow	$5.4M	↓ 3755.75%

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-4.7M	↑ 0.0%
Investing Cash Flow	$-374.3K	-
Financing Cash Flow	$3.5M	↑ 0.0%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-8.1M	↑ 74.96%
Investing Cash Flow	$-420.7K	↑ 12.39%
Financing Cash Flow	$2.6M	↓ 26.39%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-8.9M	↑ 9.83%
Investing Cash Flow	$221.8K	↓ 152.74%
Financing Cash Flow	$14.0M	↑ 450.63%

Mainz Biomed Nv Technicals Summary

Sell

Neutral

Buy

Mainz Biomed Nv is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Mainz Biomed Nv Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Mainz Biomed Nv	23.31%	-67.65%	-89.56%	-99.52%	-99.59%
Agilent Technologies Inc.	9.48%	-0.51%	-9.55%	-2.51%	24.3%
Idexx Laboratories, Inc.	20.87%	47.74%	37.7%	84.56%	62.07%
Thermo Fisher Scientific, Inc.	5.33%	-5.93%	-18.77%	-10.56%	13.57%
Danaher Corp.	4.43%	0.1%	-22.08%	-24.82%	-1.19%
Iqvia Holdings Inc.	2.55%	3.11%	-23.4%	-9.93%	15.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Mainz Biomed Nv	NA	NA	NA	-3.9	-4.66	-0.8	NA	2.61
Agilent Technologies Inc.	29.29	29.29	1.84	5.57	0.2	0.08	0.0	22.46
Idexx Laboratories, Inc.	53.78	53.78	4.84	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.33	28.33	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.68	43.68	2.06	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.61	27.61	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Mainz Biomed Nv	Buy	$7.6M	-99.59%	NA	0.0%
Agilent Technologies Inc.	Buy	$35.7B	24.3%	29.29	17.97%
Idexx Laboratories, Inc.	Buy	$51.8B	62.07%	53.78	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.9B	13.57%	28.33	15.24%
Danaher Corp.	Buy	$147.0B	-1.19%	43.68	14.21%
Iqvia Holdings Inc.	Buy	$32.4B	15.42%	27.61	7.88%

About Mainz Biomed Nv

Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.

Organization	Mainz Biomed Nv
Employees	19
CEO	Mr. Guido Baechler
Industry	Miscellaneous

Key Management of Mainz Biomed Nv

Name	Title
Mr. Guido Baechler	CEO & Executive Director
Dr. Christopher Von Toerne P.M.P., Ph.D.	Chief Operating Officer
Dr. Frank Krieg-Schneider	Chief Technology Officer
Dr. Moritz Eidens Ph.D.	Chief Science Officer & Executive Director
Mr. Stefan Erlach	Head of Human Resources
Mr. Philipp Freese	Chief Business Officer

Important FAQs about investing in MYNZ Stock from India :

What is Mainz Biomed Nv share price today?

Mainz Biomed Nv share price today is $1.66 as on August 30, 2025 at 1:29 am IST at the close of the market. Mainz Biomed Nv share today touched a day high of $1.66 and a low of $1.63.

What is the 52 week high and 52 week low for Mainz Biomed Nv share?

Mainz Biomed Nv share touched a 52 week high of $16.32 and a 52 week low of $1.30. Mainz Biomed Nv stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $1.66, lower by 89.83% versus the 52 week high.

How to invest in Mainz Biomed Nv Stock (MYNZ) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Mainz Biomed Nv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mainz Biomed Nv Shares that will get you 0.9036 shares as per Mainz Biomed Nv share price of $1.66 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Mainz Biomed Nv Stock (MYNZ) from India?

Indian investors can start investing in Mainz Biomed Nv (MYNZ) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Mainz Biomed Nv stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Mainz Biomed Nv share’s latest price of $1.66 as on August 30, 2025 at 1:29 am IST, you will get 6.0241 shares of Mainz Biomed Nv. Learn more about fractional shares .

What are the returns that Mainz Biomed Nv has given to Indian investors in the last 5 years?

Mainz Biomed Nv stock has given -99.59% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?